Benzinga | Aug 11, 2020 07:43AM EDT

BridgeBio Pharma Q2 EPS $(1.03) Down From $(0.71) YoY; Ended Quarter With $840.9M In Cash And Equivalents

BridgeBio Pharma (NASDAQ:BBIO) reported quarterly losses of $(1.03) per share. This is a 45.07 percent decrease over losses of $(0.71) per share from the same period last year.